title: Fulminant hepatic failure associated with triazolam.
authors.affiliation: First Department of Medicine, Chiba University School of Medicine, Inohana, Japan.
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Kanda
authors.forename: Osamu
authors.initials: O
authors.lastname: Yokosuka
authors.forename: Keiichi
authors.initials: K
authors.lastname: Fujiwara
authors.forename: Hiromitsu
authors.initials: H
authors.lastname: Saisho
authors.forename: Hidetoshi
authors.initials: H
authors.lastname: Shiga
authors.forename: Shigeto
authors.initials: S
authors.lastname: Oda
authors.forename: Keiko
authors.initials: K
authors.lastname: Okuda
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Sugawara
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Makuuchi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Hirasawa
mesh_terms: D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced*; D008875:Middle Aged; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D014229:Triazolam / Q000009:adverse effects*
chemical_list: D014151:Anti-Anxiety Agents; D014229:Triazolam